---

---

symbols : Azn   

save search

---

Non-invasive Glucose Monitoring Devices Market to Grow by USD 22.49 Mn, Abbott Laboratories and BlueSemi Among Key Vendors - Technavio
Published: 2023-02-13 (Crawled : 00:00) - prnewswire.com
AZNCF | $140.15 -4.19% 560 |

Health Technology

| -2.85% | O: 0.43% H: 1.52% C: -1.88%
NVSEF | $93.6375 6.88% 82K |

Health Technology

| 28.82% | O: 0.34% H: 0.0% C: 0.0%
MMAT | $2.62 -3.68% -3.82% 88K |

Mining, Quarrying, and Oil and ...

| 252.77% | O: 0.98% H: 2.0% C: -1.93%
NVS | $92.57 -0.55% 0.0% 910K |

Health Technology

| 6.39% | O: 0.27% H: 0.42% C: -0.21%
MDT | $79.19 0.14% 0.0% 6.1M |

Health Technology

| -6.29% | O: -0.34% H: 0.48% C: -0.83%
BAX | $39.65 0.33% 0.0% 2.3M |

Health Technology

| -1.98% | O: 0.0% H: 0.54% C: -1.46%
ABBV | News | $164.66 0.25% -0.15% 4.5M |

Health Technology

| 7.44% | O: 0.12% H: 0.05% C: -0.86%
ABT | News | $105.27 -0.6% -0.15% 7.3M |

Health Technology

| -1.95% | O: -0.3% H: 0.14% C: -0.86%
NMRD | $0.1053 -28.78% 820K |

Health Technology

| -93.8% | O: 3.88% H: 0.0% C: -5.97%
AZN | $68.36 -0.25% -0.25% 4M |

Health Technology

| -2.07% | O: 0.3% H: 0.94% C: 0.6%
market

---

HDAC (Histone Deacetylase) Inhibitors Market to Grow by USD 172.61 Mn, Curis Inc. and Bristol Myers Squibb Co. Among Key Vendors - Technavio
Published: 2023-02-13 (Crawled : 23:00) - prnewswire.com
AZNCF | $140.15 -4.19% 560 |

Health Technology

| -2.85% | O: 0.43% H: 1.52% C: -1.88%
NVSEF | $93.6375 6.88% 82K |

Health Technology

| 28.82% | O: 0.34% H: 0.0% C: 0.0%
VIRX | $0.8971 -4.18% -4.36% 79K |

Manufacturing

| -51.17% | O: 1.3% H: 7.18% C: 2.56%
NVS | $92.57 -0.55% 0.0% 910K |

Health Technology

| 6.39% | O: 0.27% H: 0.42% C: -0.21%
AZN | $68.36 -0.25% -0.25% 4M |

Health Technology

| -2.07% | O: 0.3% H: 0.94% C: 0.6%
market

---

Reata Announces the Appointments of Christy J. Oliger and Shamim Ruff to Its Board of Directors
Published: 2021-04-15 (Crawled : 11:00) - globenewswire.com
ABT | News | $105.27 -0.6% -0.15% 7.3M |

Health Technology

| -12.43% | O: 0.74% H: 1.86% C: 1.26%
STOK | $11.66 -0.51% -0.51% 1.1M |

Health Technology

| -65.84% | O: 1.66% H: 0.06% C: -5.65%
SRPT | $116.59 -1.1% -1.12% 500K |

Health Technology

| 60.55% | O: 0.61% H: 2.56% C: -1.69%
SNY | News | $45.395 -1.55% -1.58% 4.4M |

Health Technology

| -9.41% | O: 0.76% H: 0.61% C: 0.14%
RETA | $172.36 0.02% 0.03% 0 |

Health Technology

| 92.04% | O: 1.17% H: 3.5% C: 1.54%
KPTI | $1.265 -8.33% -9.09% 1.3M |

Health Technology

| -87.45% | O: 0.39% H: 1.37% C: -5.37%
AZN | $68.36 -0.25% -0.25% 4M |

Health Technology

| 36.97% | O: 1.81% H: 1.08% C: 0.18%
AMGN | $262.77 -0.49% -0.49% 2M |

Health Technology

| 6.14% | O: 0.59% H: 2.35% C: 1.6%

---

PARP Inhibitors Market to reach over USD 10.31 billion by the year 2031 - Exclusive Report by InsightAce Analytic
Published: 2024-02-21 (Crawled : 09:00) - prnewswire.com
AZNCF | $140.15 -4.19% 560 |

Health Technology

| 5.3% | O: -0.88% H: 1.75% C: -0.29%
JNJ | News | $145.74 0.67% 0.0% 9.3M |

Health Technology

| -7.56% | O: 0.8% H: 0.0% C: 0.0%
ABBV | News | $164.66 0.25% -0.15% 4.5M |

Health Technology

| -6.57% | O: -0.25% H: 0.0% C: 0.0%
KPTI | $1.265 -8.33% -9.09% 1.3M |

Health Technology

| 5.79% | O: -1.65% H: 3.36% C: 1.68%
CKPT | $1.595 -4.49% -4.7% 470K |

Health Technology

| -14.65% | O: 0.0% H: 1.26% C: -3.03%
AZN | $68.36 -0.25% -0.25% 4M |

Health Technology

| 4.96% | O: -1.01% H: 1.1% C: 1.1%
report year reach market

---

Human Papillomavirus Vaccine (HPV) Market to Reach $10.8 Bn, Globally, by 2031 at 12.4% CAGR: Allied Market Research
Published: 2022-07-21 (Crawled : 13:00) - prnewswire.com
GLAXF | $20.2 -14.18% 510 |

Health Technology

| -1.32% | O: 6.64% H: 0.0% C: -4.08%
SNYNF | News | $92.7 -2.18% 1.4K |

Health Technology

| -11.58% | O: -2.38% H: 0.0% C: 0.0%
AZNCF | $140.15 -4.19% 560 |

Health Technology

| 4.15% | O: 0.15% H: 0.0% C: -3.5%
NVS | $92.57 -0.55% 0.0% 910K |

Health Technology

| 10.52% | O: 0.09% H: 1.9% C: 1.89%
JNJ | News | $145.74 0.67% 0.0% 9.3M |

Health Technology

| -15.81% | O: -1.18% H: 0.0% C: 0.0%
GSK | $39.27 -0.83% 0.01% 2.2M |

Health Technology

| -4.81% | O: 1.3% H: 0.38% C: -0.38%
XBIO | $4.165 7.9% 7.32% 7.9K |

Health Technology

| -95.36% | O: 0.41% H: 7.44% C: -2.71%
SNY | News | $45.395 -1.55% -1.58% 4.4M |

Health Technology

| -10.57% | O: -3.38% H: 0.0% C: 0.0%
INO 3 d | $10.22 -7.68% -8.32% 400K |

Health Technology

| 357.4% | O: 0.0% H: 1.35% C: -5.83%
AZN | $68.36 -0.25% -0.25% 4M |

Health Technology

| 3.76% | O: -2.75% H: 2.31% C: 2.15%
research vaccine market

---

Cellular Immunotherapy Market Research Report by Type, Indication, Technology Type, End Use, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19
Published: 2022-11-10 (Crawled : 17:00) - prnewswire.com
GLAXF | $20.2 -14.18% 510 |

Health Technology

| 29.9% | O: -0.06% H: 0.0% C: 0.0%
AZNCF | $140.15 -4.19% 560 |

Health Technology

| 12.29% | O: 6.22% H: 3.13% C: -0.56%
NVS | $92.57 -0.55% 0.0% 910K |

Health Technology

| 12.19% | O: 2.81% H: 0.43% C: -0.2%
JNJ | News | $145.74 0.67% 0.0% 9.3M |

Health Technology

| -16.77% | O: 0.18% H: 0.0% C: 0.0%
GSK | $39.27 -0.83% 0.01% 2.2M |

Health Technology

| 22.15% | O: 2.59% H: 0.72% C: 0.63%
BMY | $48.3 0.96% -0.1% 11M |

Health Technology

| -39.46% | O: 1.22% H: 0.01% C: -1.7%
IOVA M | $11.72 -0.68% -0.68% 3.6M |

Health Technology

| 50.51% | O: 6.12% H: 4.99% C: 4.21%
INO 3 d | $10.22 -7.68% -8.32% 400K |

Health Technology

| 367.89% | O: 5.5% H: 4.35% C: 3.48%
GILD | News | $66.16 -1.15% -1.16% 6.4M |

Health Technology

| -18.73% | O: 1.43% H: 0.36% C: -1.08%
ATRA | $0.6917 -3.25% -3.35% 830K |

Health Technology

| -82.43% | O: 2.58% H: 23.12% C: 20.85%
AZN | $68.36 -0.25% -0.25% 4M |

Health Technology

| 11.82% | O: 7.08% H: 0.84% C: -0.43%
ADAP | $0.8984 -8.98% -9.86% 3.3M |

Health Technology

| -50.95% | O: 0.0% H: 7.14% C: 5.71%
covid-19 research global immunotherapy report impact technology market

---

U.S. Gastroesophageal Reflux Disease Devices Market Report 2022-2027: Key Players AstraZeneca, Pfizer, Procter & Gamble & Others Driving 15.47% Growth
Published: 2022-07-29 (Crawled : 20:00) - prnewswire.com
AZNCF | $140.15 -4.19% 560 |

Health Technology

| Email alert Add to watchlist
MDGS | $2.48 13.78% 12.11% 25K |

Health Technology

| Email alert Add to watchlist
TAK | News | $13.16 0.08% 0.0% 1.3M |

Health Technology

| Email alert Add to watchlist
AZN | $68.36 -0.25% -0.25% 4M |

Health Technology

| Email alert Add to watchlist
disease report growth market

---

Global Glioblastoma Multiforme (GBM) Treatment Market Report 2023: Increasing Prevalence of Brain Disorders is Expected to Propel Growth
Published: 2023-05-17 (Crawled : 01:00) - prnewswire.com
AZNCF | $140.15 -4.19% 560 |

Health Technology

| -10.51% | O: -1.32% H: 0.92% C: -1.34%
NVS | $92.57 -0.55% 0.0% 910K |

Health Technology

| -9.46% | O: -0.51% H: 0.0% C: -1.05%
FUSN | $21.24 0.0% 330K |

Health Technology

| 365.79% | O: -1.54% H: 1.34% C: -2.67%
DFFN 4 | $6.6 11.68% -34.32% 350K |

Health Technology

| 14.59% | O: -0.25% H: 0.0% C: -0.78%
AZN | $68.36 -0.25% -0.25% 4M |

Health Technology

| -9.32% | O: 0.07% H: 0.03% C: -0.84%
AMGN | $262.77 -0.49% -0.49% 2M |

Health Technology

| 16.26% | O: -0.82% H: 0.03% C: -0.44%
propel report expected treatment global growth glioblastoma market

---

Fortress Biotech Reports Record 2021 Financial Results and Recent Corporate Highlights
Published: 2022-03-28 (Crawled : 13:20) - biospace.com/
DERM | $3.54 -8.29% -9.04% 190K |

| -16.67% | O: 1.25% H: 2.23% C: 1.58%
AZNCF | $140.15 -4.19% 560 |

Health Technology

| 0.52% | O: -0.88% H: 0.0% C: 0.0%
LLY | $745.95 -0.64% -0.1% 1.7M |

Health Technology

| 159.76% | O: 0.8% H: 0.39% C: 0.11%
MBIO | $0.3819 -0.55% -1.05% 200K |

Health Technology

| -64.81% | O: -0.93% H: 3.74% C: -0.93%
FBIO | $1.81 2.26% 2.21% 440K |

Health Technology

| 31.34% | O: 2.99% H: 4.35% C: 2.9%
AZN | $68.36 -0.25% -0.25% 4M |

Health Technology

| 4.81% | O: 0.0% H: 0.71% C: 0.38%
results biotech

---

Fortress Biotech Announces Virtual Two-Day R&D Summit Hosted by B. Riley Securities on Tuesday, April 5 and Wednesday, April 6, 2022
Published: 2022-04-01 (Crawled : 17:00) - biospace.com/
DERM | $3.54 -8.29% -9.04% 190K |

| -21.33% | O: 1.86% H: 0.0% C: -1.42%
AZNCF | $140.15 -4.19% 560 |

Health Technology

| 0.5% | O: -4.03% H: 3.34% C: 3.13%
MBIO | $0.3819 -0.55% -1.05% 200K |

Health Technology

| -62.38% | O: 0.99% H: 4.9% C: 1.96%
FBIO | $1.81 2.26% 2.21% 440K |

Health Technology

| 29.41% | O: 1.47% H: 3.62% C: 1.45%
CKPT | $1.595 -4.49% -4.7% 470K |

Health Technology

| -4.52% | O: 1.69% H: 1.11% C: -1.67%
AZN | $68.36 -0.25% -0.25% 4M |

Health Technology

| 2.9% | O: -0.92% H: 1.76% C: 1.64%
biotech

---

Fortress Biotech Reports Third Quarter 2022 Financial Results and Recent Corporate Highlights
Published: 2022-11-14 (Crawled : 22:00) - globenewswire.com
DERM | $3.54 -8.29% -9.04% 190K |

| 82.69% | O: 3.37% H: 0.0% C: -2.83%
AZNCF | $140.15 -4.19% 560 |

Health Technology

| 7.01% | O: 1.42% H: 0.0% C: -1.79%
MBIO | $0.3819 -0.55% -1.05% 200K |

Health Technology

| -94.83% | O: -4.08% H: 8.87% C: 1.83%
FBIO | $1.81 2.26% 2.21% 440K |

Health Technology

| 105.37% | O: 2.68% H: 0.0% C: 0.0%
ATXI | $0.1311 -2.96% -3.05% 290K |

Health Technology

| -92.86% | O: -3.85% H: 2.86% C: -5.14%
AZN | $68.36 -0.25% -0.25% 4M |

Health Technology

| 6.81% | O: 1.05% H: 0.36% C: -0.98%
biotech financial results

---

Fortress Biotech Reports First Quarter 2023 Financial Results and Recent Corporate Highlights
Published: 2023-05-15 (Crawled : 20:00) - globenewswire.com
DERM | $3.54 -8.29% -9.04% 190K |

| 162.07% | O: 2.41% H: 8.42% C: 1.01%
AZNCF | $140.15 -4.19% 560 |

Health Technology

| -9.46% | O: 1.17% H: 0.0% C: 0.0%
MBIO | $0.3819 -0.55% -1.05% 200K |

Health Technology

| -91.26% | O: 0.0% H: 1.24% C: -0.23%
FBIO | $1.81 2.26% 2.21% 440K |

Health Technology

| 148.94% | O: 4.67% H: 1.34% C: -10.55%
CKPT | $1.595 -4.49% -4.7% 470K |

Health Technology

| -40.28% | O: 1.41% H: 2.79% C: -2.79%
ATXI | $0.1311 -2.96% -3.05% 290K |

Health Technology

| -87.85% | O: 0.0% H: 0.0% C: 0.0%
AZN | $68.36 -0.25% -0.25% 4M |

Health Technology

| -8.97% | O: 0.44% H: 0.44% C: -0.05%
biotech financial results

---

Fortress Biotech Reports Second Quarter 2023 Financial Results and Recent Corporate Highlights
Published: 2023-08-14 (Crawled : 20:00) - globenewswire.com
DERM | $3.54 -8.29% -9.04% 190K |

| 74.31% | O: -2.75% H: 4.01% C: -0.47%
AZNCF | $140.15 -4.19% 560 |

Health Technology

| -5.51% | O: -1.75% H: 0.0% C: -2.23%
MBIO | $0.3819 -0.55% -1.05% 200K |

Health Technology

| -90.57% | O: 0.0% H: 0.07% C: -5.71%
FBIO | $1.81 2.26% 2.21% 440K |

Health Technology

| 227.14% | O: -8.92% H: 0.0% C: 0.0%
CKPT | $1.595 -4.49% -4.7% 470K |

Health Technology

| -19.14% | O: -0.96% H: 2.42% C: -2.42%
ATXI | $0.1311 -2.96% -3.05% 290K |

Health Technology

| -87.31% | O: -2.37% H: 4.0% C: 0.0%
AZN | $68.36 -0.25% -0.25% 4M |

Health Technology

| -3.63% | O: -1.27% H: 0.26% C: -0.61%
biotech financial results

---

Fortress Biotech Reports 2023 Financial Results and Recent Corporate Highlights
Published: 2024-03-28 (Crawled : 20:00) - globenewswire.com
AZNCF | $140.15 -4.19% 560 |

Health Technology

| Email alert Add to watchlist
FBIO | $1.81 2.26% 2.21% 440K |

Health Technology

| Email alert Add to watchlist
DERM | $3.54 -8.29% -9.04% 190K |

| Email alert Add to watchlist
MBIO | $0.3819 -0.55% -1.05% 200K |

Health Technology

| Email alert Add to watchlist
AZN | $68.36 -0.25% -0.25% 4M |

Health Technology

| Email alert Add to watchlist
CKPT | $1.595 -4.49% -4.7% 470K |

Health Technology

| Email alert Add to watchlist
biotech financial results

---

Global MRSA Drugs Markets, 2017-2022, 2022-2027F, 2032F: Focus on Lipopeptides, Oxazolidinones, Cephalosporin, Tetracycline, Folate Antagonist, & Lipoglycopeptide
Published: 2023-09-08 (Crawled : 17:00) - prnewswire.com
AZNCF | $140.15 -4.19% 560 |

Health Technology

| 0.46% | O: 0.86% H: 0.0% C: -0.1%
IPIX | $0.01 92.86% 590K |

Manufacturing

| -40.48% | O: 0.0% H: 1.19% C: 0.6%
ABBV | News | $164.66 0.25% -0.15% 4.5M |

Health Technology

| 10.91% | O: 0.07% H: 0.0% C: 0.0%
CPIX | $1.57 6.02% 1.4K |

Health Technology

| -6.59% | O: -2.99% H: 0.0% C: 0.0%
AZN | $68.36 -0.25% -0.25% 4M |

Health Technology

| 0.39% | O: 0.49% H: 0.24% C: -0.16%
global

---

Anti-rheumatic Market to Grow Exponentially by 2029- Brandessence Market Research
Published: 2023-09-01 (Crawled : 14:30) - prnewswire.com
AZNCF | $140.15 -4.19% 560 |

Health Technology

| 0.94% | O: 1.46% H: 0.0% C: 0.0%
ALPMY | $9.46 -1.11% 500K |

Manufacturing

| -38.31% | O: -0.07% H: 3.3% C: 0.26%
ABBV | News | $164.66 0.25% -0.15% 4.5M |

Health Technology

| 11.26% | O: -0.35% H: 0.0% C: 0.0%
CPIX | $1.57 6.02% 1.4K |

Health Technology

| -5.45% | O: 0.61% H: 0.0% C: 0.0%
BIIB | $190.55 -0.84% -0.84% 1.5M |

Health Technology

| -27.01% | O: 0.62% H: 0.26% C: -0.68%
AZN | $68.36 -0.25% -0.25% 4M |

Health Technology

| 0.66% | O: 0.86% H: 0.16% C: -0.38%
AMGN | $262.77 -0.49% -0.49% 2M |

Health Technology

| 3.35% | O: 0.91% H: 0.14% C: -0.76%
research market

---

Global $4+ Billion SERD Therapeutics Market to 2030: Faslodex, RAD1901, GDC-9545, AZD9833, SAR439859
Published: 2021-04-28 (Crawled : 15:00) - prnewswire.com
NVS | $92.57 -0.55% 0.0% 910K |

Health Technology

| 7.43% | O: -0.37% H: 0.7% C: 0.58%
LLY | $745.95 -0.64% -0.1% 1.7M |

Health Technology

| 312.04% | O: -0.42% H: 0.3% C: -0.5%
SNY | News | $45.395 -1.55% -1.58% 4.4M |

Health Technology

| -11.73% | O: 1.86% H: 0.89% C: 0.11%
GTHX | $4.16 -2.8% -2.88% 690K |

Health Technology

| -81.67% | O: -1.54% H: 3.04% C: 1.03%
AZN | $68.36 -0.25% -0.25% 4M |

Health Technology

| 30.35% | O: -0.02% H: 0.46% C: -0.53%

---

Global Dental Turbine Market Research Report (2021 to 2027) - by Product Type, Turbine Speed, End User and Region
Published: 2022-03-21 (Crawled : 16:00) - prnewswire.com
AZNCF | $140.15 -4.19% 560 |

Health Technology

| 5.77% | O: 0.0% H: 0.06% C: -4.79%
NVSEF | $93.6375 6.88% 82K |

Health Technology

| 11.54% | O: 3.7% H: 0.0% C: 0.0%
ALPMY | $9.46 -1.11% 500K |

Manufacturing

| -42.06% | O: 0.06% H: 0.07% C: -0.06%
TAK | News | $13.16 0.08% 0.0% 1.3M |

Health Technology

| -12.91% | O: -0.33% H: 0.47% C: 0.47%
NVS | $92.57 -0.55% 0.0% 910K |

Health Technology

| 7.25% | O: -0.14% H: 0.0% C: 0.0%
LLY | $745.95 -0.64% -0.1% 1.7M |

Health Technology

| 161.01% | O: 0.04% H: 2.63% C: 0.65%
BMY | $48.3 0.96% -0.1% 11M |

Health Technology

| -31.32% | O: 1.61% H: 0.0% C: 0.0%
GTHX | $4.16 -2.8% -2.88% 690K |

Health Technology

| -52.99% | O: -0.23% H: 1.02% C: -6.44%
CLDX | $38.49 -2.88% -2.96% 580K |

Health Technology

| 9.52% | O: -0.03% H: 0.51% C: -4.39%
AZN | $68.36 -0.25% -0.25% 4M |

Health Technology

| 7.96% | O: -0.02% H: 0.0% C: 0.0%
research report

---

NeuroBo Pharmaceuticals Appoints Gil Price, M.D. as President and Chief Executive Officer
Published: 2021-11-04 (Crawled : 02:00) - biospace.com/
GLAXF | $20.2 -14.18% 510 |

Health Technology

| -3.07% | O: 2.29% H: 0.0% C: -2.0%
AZNCF | $140.15 -4.19% 560 |

Health Technology

| 4.89% | O: 0.13% H: 0.58% C: 0.58%
GSK | $39.27 -0.83% 0.01% 2.2M |

Health Technology

| -9.03% | O: -1.29% H: 0.0% C: 0.0%
SRPT | $116.59 -1.1% -1.12% 500K |

Health Technology

| 36.24% | O: 1.7% H: 0.0% C: 0.0%
NRBO | $3.425 -1.01% -1.02% 23K |

Health Technology

| 70.02% | O: 0.25% H: 0.0% C: 0.0%
AZN | $68.36 -0.25% -0.25% 4M |

Health Technology

| 6.95% | O: -0.05% H: 0.0% C: 0.0%

---

The Worldwide mRNA Therapeutics Industry is Expected to Reach $37.7 billion by 2030
Published: 2022-12-15 (Crawled : 17:00) - prnewswire.com
AZNCF | $140.15 -4.19% 560 |

Health Technology

| -3.19% | O: 0.14% H: 0.4% C: -1.41%
SGMO | $0.4853 -5.95% -6.33% 1.7M |

Health Technology

| -84.93% | O: -1.16% H: 1.17% C: -3.23%
MRNA S | $102.015 -1.38% -1.4% 1.7M |

Health Technology

| -50.5% | O: -0.64% H: 2.33% C: -0.17%
CVAC | News | $2.44 -5.06% -5.33% 710K |

Health Technology

| -65.97% | O: -1.39% H: 1.41% C: -4.24%
CRSP M | $56.14 1.04% 1.03% 1.7M |

Health Technology

| 15.48% | O: -2.23% H: 2.67% C: -3.2%
BNTX | $86.19 -0.24% -0.24% 580K |

Health Technology

| -53.68% | O: 0.13% H: 1.45% C: -2.28%
AZN | $68.36 -0.25% -0.25% 4M |

Health Technology

| -3.09% | O: -0.58% H: 0.11% C: -0.41%
expected mrna therapeutics

---

Gainers vs Losers

64%

36%

Top 10 Gainers

AGBA | News | $1.02 155.0% 57.94% 120M |

Finance

ZCMD | $2.86 108.76% 52.1% 2.3M |

Commercial Services

INVO | $1.555 104.6% 51.13% 5M |

Health Technology

ISPC | $0.437 105.16% 49.53% 37M |

Professional, Scientific, and T...

WLGS | News | $0.92 84.0% 45.65% 1.6M |

OST | $0.499 21.38% 45.26% 1.9M |

XPON | News | $3.1 60.62% 37.74% 17M |

TIRX | $0.7 44.39% 30.74% 58M |

BNTC | News | $6.92 44.17% 30.64% 3.5M |

Health Technology

GGE | $0.035 19.86% 29.3% 64M |

---

Your saved searches

---